Biocon gets nod to sell Yesintek in 9 more markets
Biocon Ltd has secured market access for Yesintek, its proposed biosimilar to Stelara, in nine additional countries through a licence agreement with Janssen Sciences Ireland. The deal covers Australia, Brazil, China, Hong…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.